vTv Therapeutics (VTVT) Interest Coverage Ratio (QoQ) (2014 - 2026)
vTv Therapeutics (VTVT) Interest Coverage Ratio (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.01% |
| Dec 31, 2025 | -268.49% |
| Mar 31, 2025 | 97.94% |
| Dec 31, 2024 | -8,359.11% |
| Sep 30, 2024 | -10.73% |
| Jun 30, 2024 | -49.43% |
| Mar 31, 2024 | 97.40% |
| Dec 31, 2023 | -5,148.65% |
| Sep 30, 2023 | 25.05% |
| Dec 31, 2022 | -11,625.65% |
| Sep 30, 2022 | -56.05% |
| Jun 30, 2022 | 32.07% |
| Mar 31, 2022 | 99.62% |
| Dec 31, 2021 | -123,394.93% |
| Sep 30, 2021 | 63.21% |
| Jun 30, 2021 | 68.58% |
| Mar 31, 2021 | -156.98% |
| Dec 31, 2020 | 1,203.34% |
| Sep 30, 2020 | 83.81% |
| Jun 30, 2020 | 36.74% |